Semax Attenuates Neurochemical Disruption from Early-Life SSRI Exposure in Rats | RemedyX Labs Research Library

A research summary of Semax, synthetic ACTH(4-10) analogue, attenuates behavioural and neurochemical alterations following early-life fluvoxamine exposure in white rats, examining semax attenuates neurochemical disruption from early-life ssri exposure in rats. Cited source and RUO context from RemedyX Labs.